Skip to content
  • Saturday, 15 August 2026
  • 2:39 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs
Environmental & Analytical Chemistry

The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs

Abdurrohim Arsyad May 18, 2026 0

In the vibrant, shallow waters off the coast of Australia, a creature of astonishing camouflage has been unveiled to the…

Read More
Environmental & Analytical Chemistry

The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs

Abdurrohim Arsyad May 18, 2026 0

A remarkable new species of ghost pipefish, colloquially dubbed the "Snuffleupagus" fish for its distinctive, trunk-like snout and uncanny camouflage,…

Read More
Environmental & Analytical Chemistry

The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs

Abdurrohim Arsyad May 18, 2026 0

In the vibrant, kaleidoscopic world of Australia’s shallow marine ecosystems, a remarkable discovery has surfaced: a new species of ghost…

Read More
Pharmaceutical R&D

Arrowhead Pharmaceuticals Secures Australian TGA Approval for Redemplo, Offering Hope for Familial Chylomicronemia Syndrome Patients

Teuku Ryan May 4, 2026 0

The Australian Therapeutic Goods Administration (TGA) has granted approval for Arrowhead Pharmaceuticals’ Redemplo (plozasiran), a novel therapeutic agent designed to…

Read More
Pharma 50: Keytruda Holds Top Brand Slot as Tirzepatide and Semaglutide Dominate at Molecule Level in FY2025King’s College London Researchers Identify KCL-286 as a Multitarget Breakthrough for Early-Stage Alzheimer’s TreatmentPrecision DNA editing targets root cause of severe childhood epilepsy in a preclinical study.Mitochondrial Pearling: Unraveling a Centuries-Old Mystery of Cellular Organization
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ